JP2025505440A5 - - Google Patents

Info

Publication number
JP2025505440A5
JP2025505440A5 JP2024545180A JP2024545180A JP2025505440A5 JP 2025505440 A5 JP2025505440 A5 JP 2025505440A5 JP 2024545180 A JP2024545180 A JP 2024545180A JP 2024545180 A JP2024545180 A JP 2024545180A JP 2025505440 A5 JP2025505440 A5 JP 2025505440A5
Authority
JP
Japan
Prior art keywords
disease
composition according
composition
disorder
cargo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024545180A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025505440A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/051650 external-priority patent/WO2023144127A1/en
Publication of JP2025505440A publication Critical patent/JP2025505440A/ja
Publication of JP2025505440A5 publication Critical patent/JP2025505440A5/ja
Pending legal-status Critical Current

Links

JP2024545180A 2022-01-31 2023-01-24 微細藻類由来の細胞外小胞、投与の際のその体内分布および使用 Pending JP2025505440A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202263305230P 2022-01-31 2022-01-31
US63/305,230 2022-01-31
US202263368975P 2022-07-20 2022-07-20
US63/368,975 2022-07-20
US202263418959P 2022-10-24 2022-10-24
US63/418,959 2022-10-24
PCT/EP2023/051650 WO2023144127A1 (en) 2022-01-31 2023-01-24 Extracellular vesicles from microalgae, their biodistribution upon administration, and uses

Publications (2)

Publication Number Publication Date
JP2025505440A JP2025505440A (ja) 2025-02-26
JP2025505440A5 true JP2025505440A5 (https=) 2026-01-29

Family

ID=93457263

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024545180A Pending JP2025505440A (ja) 2022-01-31 2023-01-24 微細藻類由来の細胞外小胞、投与の際のその体内分布および使用

Country Status (4)

Country Link
US (1) US20240423923A1 (https=)
EP (1) EP4472649A1 (https=)
JP (1) JP2025505440A (https=)
CA (1) CA3250091A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119633027A (zh) * 2025-02-19 2025-03-18 深圳大学 裸藻在制备用于预防和/或辅助治疗缺血性脑卒中的产品中的应用
CN120131958B (zh) * 2025-03-12 2026-04-07 广东药科大学 Tlr1受体抑制剂在制备治疗高血压产品中的应用

Similar Documents

Publication Publication Date Title
JP2024528697A5 (https=)
US12465575B2 (en) Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons
JP2025505440A5 (https=)
Jiang et al. The potential of mannosylated chitosan microspheres to target macrophage mannose receptors in an adjuvant-delivery system for intranasal immunization
US20250092083A1 (en) Sterol based ionizable lipids and lipid nanoparticles comprising the same
US20170157048A1 (en) Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
US11065331B2 (en) Immune adjuvant for cancer
Liu et al. Encapsulation of Poly I: C and the natural phosphodiester CpG ODN enhanced the efficacy of a hyaluronic acid-modified cationic lipid-PLGA hybrid nanoparticle vaccine in TC-1-grafted tumors
JP5692887B1 (ja) ポリマーミセル医薬組成物
US20230149456A1 (en) Nanoparticle-loaded silicified cells, methods of making, and methods of use
US20250332283A1 (en) Nucleotide delivery from injectable hydrophobic biomaterial
CN117187252A (zh) Toll样受体激动剂及其应用
US20190307703A1 (en) Multi-functional nanoparticles for vaccination
KR102901149B1 (ko) 에멀전 제형의 면역증강제 조성물 및 이의 제조 방법
JP7847768B2 (ja) 粘膜粘着性－ｐｌｇａナノ粒子
EP4585212A1 (en) Kit for manufacture of drug-containing nanoparticles and nanoparticle composition for drug delivery
WO2023235303A1 (en) Vaccine compositions and uses thereof
TW202404614A (zh) 免疫增強及感染性疾病之治療
WO2024092352A1 (en) Compositions that recruit and activate antigen presenting cells
Hou Lipid Nanoparticle-Messenger RNA Formulations against Infections
WO2025176843A1 (en) Microalgae extracellular vesicle based gene therapy vectors (mev-gtvs), their preparation, and uses thereof
WO2025257084A1 (en) Lipid composition
Molavi Delivery of STAT3 inhibitor cucurbitacins to tumor by polymeric nano-carriers: Implications in cancer chemo-and immunotherapy
Chen Control of endosomal Toll-like receptor (TLR) signaling by nanoparticles and applications in cancer therapy
松尾 et al. Development of highly immunogenic vaccine by using dendritic cell-targeting bio-nanocapsule